Which regulatory classification applies to high-risk in vitro diagnostic devices requiring premarket approval?

Which regulatory classification applies to high-risk in vitro diagnostic devices requiring premarket approval?

• A. Class I (general controls)
• B. Class II (special controls)
• C. Class III (general controls and premarket approval)
• D. Exemption from regulation

Answer: (C)

Regulatory oversight for medical devices uses a risk-based system: the higher the risk a device poses to patients, the more stringent the review. High-risk in vitro diagnostic devices that could significantly impact patient safety require the most rigorous evidence of safety and effectiveness, which is provided through premarket approval. PMA is FDA’s process that demands substantial clinical data, manufacturing controls, and a comprehensive safety and effectiveness package before the device can be marketed. Because these high‑risk diagnostics must be proven thoroughly before use, they fall under Class III, which combines general controls with PMA. Lower-risk devices typically rely on general controls and, for some, additional, but less stringent, safeguards (Class I). Some devices are regulated under Class II with special controls designed to address moderate risk, without requiring the full PMA process. Others are exempt from regulation altogether. The requirement for premarket approval distinguishes the highest-risk category, making Class III the correct classification for high-risk IVDs requiring PMA.

Regulatory oversight for medical devices uses a risk-based system: the higher the risk a device poses to patients, the more stringent the review. High-risk in vitro diagnostic devices that could significantly impact patient safety require the most rigorous evidence of safety and effectiveness, which is provided through premarket approval. PMA is FDA’s process that demands substantial clinical data, manufacturing controls, and a comprehensive safety and effectiveness package before the device can be marketed. Because these high‑risk diagnostics must be proven thoroughly before use, they fall under Class III, which combines general controls with PMA.

Lower-risk devices typically rely on general controls and, for some, additional, but less stringent, safeguards (Class I). Some devices are regulated under Class II with special controls designed to address moderate risk, without requiring the full PMA process. Others are exempt from regulation altogether. The requirement for premarket approval distinguishes the highest-risk category, making Class III the correct classification for high-risk IVDs requiring PMA.